National Center for Complementary & Alternative Medicine; Amended Notice of Meeting, 4052 [2012-1702]
Download as PDF
<![CDATA[
4052
Federal Register / Vol. 77, No. 17 / Thursday, January 26, 2012 / Notices
Bethesda, MD 20817, (301) 594–5019,
charles.rafferty@nih.gov.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases, Special Emphasis Panel, P50
Centers of Research Translation Review.
Date: March 8–9, 2012.
Time: 8 a.m. to 5 p.m.
Agenda : To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Kan Ma, Ph.D., Scientific
Review Officer, National Institute of
Arthritis, Musculoskeletal and Skin Diseases,
National Institutes of Health, 6701
Democracy Boulevard, Suite 800, Bethesda,
MD 20817, (301) 451–4838, mak2@mail.nih.
gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: January 19, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/irg/irg.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: January 19, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–1678 Filed 1–25–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2012–1682 Filed 1–25–12; 8:45 am]
National Institutes of Health
BILLING CODE 4140–01–P
National Center for Complementary &
Alternative Medicine; Amended Notice
of Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
mstockstill on DSK4VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Initial Review Group, Subcommittee
I—Career Development.
Date: February 21, 2012.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Alexandria Old Town, 1767
King Street, Alexandria, VA 22314.
Contact Person: Sergei Radaev, Ph.D.,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Blvd., Rm
8113, Bethesda, MD 20892, (301) 435–5655,
sradaev@mail.nih.gov.
VerDate Mar<15>2010
17:14 Jan 25, 2012
Jkt 226001
Notice is hereby given of a change in
the meeting of the National Advisory
Council for Complementary and
Alternative Medicine, February 3, 2012,
8:30 a.m. to February 3, 2012, 4 p.m.,
National Institutes of Health, Building
31, 31 Center Drive, Bethesda, MD,
20892 which was published in the
Federal Register on December 21, 2011,
76 FR 79202.
This meeting has been amended so
that the open session will begin at 10
a.m. instead of 10:45 am. The public
comment period will be from 3:30 p.m.
to 3:45 p.m. The meeting is partially
Closed to the public.
Dated: January 20, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–1702 Filed 1–25–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Topics in
Bioengineering Sciences and Technologies.
Date: February 9–10, 2012.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Joseph D Mosca, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5158,
MSC 7808, Bethesda, MD 20892, (301) 435–
2344, moscajos@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 20, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–1699 Filed 1–25–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Review of
P01 Grant Applications (SEP One).
E:\FR\FM\26JAN1.SGM
26JAN1
]]>Agencies
[Federal Register Volume 77, Number 17 (Thursday, January 26, 2012)]
[Notices]
[Page 4052]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-1702]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Complementary & Alternative Medicine; Amended
Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Advisory Council for Complementary and Alternative Medicine, February
3, 2012, 8:30 a.m. to February 3, 2012, 4 p.m., National Institutes of
Health, Building 31, 31 Center Drive, Bethesda, MD, 20892 which was
published in the Federal Register on December 21, 2011, 76 FR 79202.
This meeting has been amended so that the open session will begin
at 10 a.m. instead of 10:45 am. The public comment period will be from
3:30 p.m. to 3:45 p.m. The meeting is partially Closed to the public.
Dated: January 20, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-1702 Filed 1-25-12; 8:45 am]
BILLING CODE 4140-01-P
